NASDAQ:TRIB - Nasdaq - US8964385046 - ADR - Currency: USD
TRINITY BIOTECH PLC-SPON ADR
NASDAQ:TRIB (1/29/2025, 8:00:02 PM)
Premarket: 1.22 -0.1 (-7.58%)1.32
-0.04 (-2.94%)
The current stock price of TRIB is 1.32 USD. In the past month the price increased by 64.61%. In the past year, price decreased by -56%.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.38 | 221.77B | ||
ISRG | INTUITIVE SURGICAL INC | 78.13 | 203.99B | ||
BSX | BOSTON SCIENTIFIC CORP | 43.52 | 151.38B | ||
SYK | STRYKER CORP | 32.08 | 149.08B | ||
MDT | MEDTRONIC PLC | 17.41 | 117.21B | ||
BDX | BECTON DICKINSON AND CO | 18.76 | 71.60B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.64 | 41.95B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.82 | 40.14B | ||
RMD | RESMED INC | 30.5 | 37.12B | ||
IDXX | IDEXX LABORATORIES INC | 38.24 | 34.29B | ||
DXCM | DEXCOM INC | 50.84 | 33.76B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.36 | 25.64B |
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The firm is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The firm develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. The company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The firm sells its products direct in the United States and through a network of international distributors.
TRINITY BIOTECH PLC-SPON ADR
Ida Business Park, Bray, Co Wicklow
DUBLIN WICKLOW IE
CEO: Ronan O'Caoimh
Employees: 380
Company Website: https://www.trinitybiotech.com/
Investor Relations: http://www.trinitybiotech.com/investor-relations/
Phone: 1135312955111
The current stock price of TRIB is 1.32 USD.
The exchange symbol of TRINITY BIOTECH PLC-SPON ADR is TRIB and it is listed on the Nasdaq exchange.
TRIB stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TRIB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TRIB.
TRIB does not pay a dividend.
TRIB does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.9).
The outstanding short interest for TRIB is 0.55% of its float.
ChartMill assigns a technical rating of 2 / 10 to TRIB. When comparing the yearly performance of all stocks, TRIB is a bad performer in the overall market: 93.61% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to TRIB. Both the profitability and financial health of TRIB have multiple concerns.
Over the last trailing twelve months TRIB reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS increased by 34.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -20.87% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 86% to TRIB. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -194.92% and a revenue growth 6.69% for TRIB